Adverse events88

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

81 to 88 of 88

Type	Event	Organ system	Group	Affected	At risk	Events
serious	Hyperkalaemia	Metabolism and nutrition disorders	Daprodustat in Period 1	0	7	0
serious	Hyperkalaemia	Metabolism and nutrition disorders	rhEPO in Period 1	0	7	0
serious	Hyperkalaemia	Metabolism and nutrition disorders	rhEPO in Period 2	0	7	0
serious	Hyperkalaemia	Metabolism and nutrition disorders	Daprodustat in Period 2	1	7	1
serious	Lumbar spinal stenosis	Musculoskeletal and connective tissue disorders	Daprodustat in Period 1	0	7	0
serious	Lumbar spinal stenosis	Musculoskeletal and connective tissue disorders	rhEPO in Period 1	0	7	0
serious	Lumbar spinal stenosis	Musculoskeletal and connective tissue disorders	rhEPO in Period 2	0	7	0
serious	Lumbar spinal stenosis	Musculoskeletal and connective tissue disorders	Daprodustat in Period 2	1	7	1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03457701/events?page=5